Foreign & Colonial Eurotrust PLC
22 January 2008
Date: 22 January 2008
Contact: Peter Jarvis
F&C Management Limited
020 7628 8000
Foreign & Colonial Eurotrust PLC
Interim Management Statement
for the quarter ended 31 December 2007
Objective
The objective of Foreign & Colonial Eurotrust PLC is to achieve long-term growth
through a diversified portfolio of Continental European securities.
Summary of Performance
Attributable to equity shareholders 31 December 2007 30 September 2007 % Change
Net assets £451.08m £464.52m -2.9
Net asset value per share 881.84p 897.31p -1.7
Share price 797.00p 812.50p -1.9
Manager's Review
Performance
Your Company's net asset value per share (adjusted to reflect the dividends of
8.3 pence per share paid on 20 December 2007) fell by 0.9% compared with a rise
of 2.8% in the FTSE World Europe Index, excluding the UK and adjusted to
sterling. The Company's share price fell by 1.9% from 812.5p to 797.0p. The
discount widened slightly from 9.5% to 9.6%. During the quarter the Company
bought back and cancelled 615,798 shares at a cost of £4,990,000.
Review of markets
The quarter saw equities in Continental Europe continue to be affected by the
global credit market turmoil and the threat of a recession in the US. In
particular, the banking sector was impacted by reports of further
sub-prime-related write-downs. Investors continued to favour government bonds
over risky assets and Euro government bond prices rose, though they lagged US
Treasuries as the European Central Bank (ECB) kept interest rates on hold.
European economic growth is slowing and in December the ECB lowered its Eurozone
GDP forecast for 2008 from 2.3% to 2%. Meanwhile, record oil prices and higher
food prices strengthened inflation, which at 3% was the highest for more than
six years. In these conditions, the ECB maintained interest rates at 4%.
The effects of the credit market problems and the threat of US recession were
reflected in tighter lending conditions and weaker economic data. Germany's Ifo
survey showed a decline in business confidence to its lowest level in almost two
years in December and a ZEW economic sentiment survey indicated a deterioration
in investor confidence. Mid month, the ECB combined with other central banks to
inject considerable cash into the money markets in an effort to encourage
stability and improve investor confidence. While this helped to alleviate
immediate concerns, the underlying issues are yet to be resolved.
Portfolio strategy
Against an increasingly uncertain environment we have maintained our focus on
seeking out companies with visible earnings and ongoing potential. With this in
mind we continue to favour areas/firms geared into Asian domestic strength like
Folli Follie, a Greek mid-range jewellery manufacturer. We topped up in
FLSmidth, which looks well placed to benefit from increased infrastructure spend
across the emerging markets, primarily through their Indian cement operations.
We established a position in the attractively valued Vivendi - a leader in
entertainment such as music, cinema and internet. We are positive on its recent
tie-up with Electronic Arts believing the deal will help them better crystallise
value in their gaming business.
A new position was established in Speedel which focuses on the development of
drugs to treat cardiovascular and metabolic diseases, and has three products in
Phase II-III clinical trials. The most advanced drug, Tekturna, is the first in
a new class of renin inhibitors for cardiovascular disease and is partnered with
Novartis.
We continued to temper our exposure to mid caps by reducing our position in
Arques Industries.
Outlook
We remain cautious on the outlook for European shares as there appears little
scope in the short-term for the market making any headway. On the positive
side, the European consumer still appears to be spending and the market is
bearing up relatively strongly against an increasingly volatile backdrop. At
the corporate level strong balance sheets and cash flow generation should pave
the way for continued earnings growth in the region.
Peter Jarvis
January 2008
Ten Largest Equity Holdings
31 December 2007 30 September Company % of total assets
2007 Sector (Country)
1 (2) Nokia 3.6
Technology hardware & equipment (Finland)
2 (1) Total 3.6
Oil & gas producers (France)
3 (-) Banco Santander 2.5
Banks (Spain)
4 (-) Bayer 2.3
Chemicals (Germany)
5 (-) Suez 2.2
Electricity (France)
6 (5) Societe Generale 2.1
Banks (France)
7 (15) Unilever 2.1
Food producers (Netherlands)
8 (4) Roche 2.0
Pharmaceuticals & biotechnology (Switzerland)
9 (6) ENI 2.0
Oil & gas producers (Italy)
10 (-) Grupo Ferrovial 1.9
Construction & materials (Spain)
Industrial Classification of Investments
31 December 2007 30 September 2007
% of total investments % of total investments
Financials 21.8 22.5
Consumer goods 19.6 14.9
Technology 11.5 11.4
Oil & gas 10.9 10.5
Basic materials 9.9 2.9
Industrials 7.8 18.7
Healthcare 7.0 8.4
Utilities 6.1 5.4
Consumer services 5.4 5.3
Further Information
Further information, including monthly factsheets and daily net asset values
published since the end of the quarter, can be found on the www.fandc.com
website.
The Board is not aware of any significant events or transactions that have
occurred between 31 December 2007 and the date of publication of this statement
which would have a material impact on the financial position of the Company.
By order of the Board
F&C Management Limited
Secretary
22 January 2008
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.